郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.

期刊：Journal of medicinal chemistry发表年份：2007作者：Vittoria Colotta; Daniela Catarzi; Flavia Varano; Francesca Capelli; Ombretta Lenzi; Guido Filacchioni; Claudia Martini; Letizia Trincavelli; Osele Ciampi; Anna Maria Pugliese; Felicita Pedata; Andrea Schiesaro; Erika Morizzo; Stefano Moro
阅读更多 →

药效评价Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin.

期刊：Nature biotechnology发表年份：2007作者：Chengbin Wu; Hua Ying; Christine Grinnell; Shaughn Bryant; Renee Miller; Anca Clabbers; Sahana Bose; Donna McCarthy; Rong-Rong Zhu; Ling Santora; Rachel Davis-Taber; Yune Kunes; Emma Fung; Annette Schwartz; Paul Sakorafas; Jijie Gu; Edit Tarcsa; Anwa
阅读更多 →

药效评价Action mechanism of tachyplesin I and effects of PEGylation.

期刊：Biochimica et biophysica acta发表年份：2007作者：Yuichi Imura; Minoru Nishida; Yoshiyuki Ogawa; Yoshinobu Takakura; Katsumi Matsuzaki
阅读更多 →

药效评价MrgD activation inhibits KCNQ/M-currents and contributes to enhanced neuronal excitability.

期刊：The Journal of neuroscience : the official journal of the Society for Neuroscience发表年份：2007作者：Robert A Crozier; Seena K Ajit; Edward J Kaftan; Mark H Pausch
阅读更多 →